Bought the ticket, hasn't taken the ride: the company has already paid for its next stage and is now waiting to be paid
The model's full reasoning — Q1 2016 call → NOThe question asks whether management describes a situation where the company has already spent or irreversibly committed resources for a stage of business it has not yet been paid back for — i.e., spending is done, return is outstanding, and payback is treated as a matter of time. Let me examine the transcript for evidence of this pattern. Key points from the call: - CUDC-907 Phase 2 trial initiated in January 2016, enrollment ongoing. The Phase 1 monotherapy arm is complete (25 patients, 8 responses). The Phase 2 is ongoing. - CA170 is expected to enter the clinic later this quarter (Q2 2016). It's not yet in the clinic. - R&D expenses increased due to "increased direct spending related to outside services supporting the ongoing clinical activities of CUDC-907, including initial costs for the Phase 2 trial that was initiated in January 2016 and direct costs for programs under the Aurigene collaboration." So the company has spent money on the Phase 2 trial (initiated January 2016) and on the Aurigene collaboration programs. The Phase 2 trial is ongoing — the spending is happening, but the results (payback) are not yet in. The company expects to present data potentially at ASH this year or 2017. Is this a case where the spending is done and the return is outstanding? The Phase 2 trial is ongoing — it's not complete. The spending is ongoing, not fully done. The trial is still enrolling. So the spending is not "done" — it's in progress. For CA170, it's expected to enter the clinic later this quarter — so the spending on that is still ahead, not done. The question asks about a situation where the company has ALREADY PAID for something and the return is still outstanding. The Phase 2 trial is ongoing — the spending is happening now, not completed. The return (data, potential approval) is in the future. But is the spending "done"? No, the trial is still enrolling and running. The spending is ongoing, not completed. Also, the payback for a clinical trial is not really a "matter of time" in the sense of a business that has built capacity and is waiting for it to fill — it's more about clinical trial results, which are uncertain. The company is spending on R&D, which is normal investment in a biotech. The returns (drug approvals, sales) are far off and uncertain. The question's criteria: "THE SPENDING IS DONE, NOT PLANNED" — the Phase 2 trial is ongoing, not done.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
PRIM · Q2 2018 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the revenue from that hasn't arrived yet. YES The transcript shows management describing the Willbros acquisition as a completed outlay: closed June 1, $165 million total paid ($38.4 million cash for shares + $123.2 million debt settlement + $3.1 million fees), net cash $111 million, funded by revolver, then refinanced 220 million term loan. This is treated as already done, not planned. The return is still largely outstanding: only one month of Willbros operations reported ($61 million revenue, $6.8 million gross profit, $2.9 million operating income in June), merger-related expenses $7.
PSX · Q4 2016 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the returns haven't come yet, and they expect them soon as a matter of time. YES Management describes the U.S. Gulf Coast Petrochemicals Project as already substantially paid for: capital spending is “reduced following the completion of the project” and “down significantly” compared with last year, with roughly $1 billion of CapEx no longer available for distribution.
TGI · Q2 2017 → YESThe question is about whether management describes having already spent money or resources for a larger operation that hasn't paid back yet. YES The transcript shows management describing a clear situation matching all three criteria. On slide 13, they report "$126 million" of year-to-date investments in development programs as a completed cash outflow ("used $126 million"), with incremental customer financing providing $100 million offset.